Free Trial

Geode Capital Management LLC Acquires 3,826 Shares of Nutex Health Inc. (NASDAQ:NUTX)

Nutex Health logo with Medical background

Geode Capital Management LLC raised its position in Nutex Health Inc. (NASDAQ:NUTX - Free Report) by 12.6% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 34,125 shares of the company's stock after buying an additional 3,826 shares during the period. Geode Capital Management LLC owned 0.63% of Nutex Health worth $1,082,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently modified their holdings of NUTX. Essex Investment Management Co. LLC grew its holdings in Nutex Health by 45.4% during the fourth quarter. Essex Investment Management Co. LLC now owns 105,809 shares of the company's stock valued at $3,353,000 after purchasing an additional 33,024 shares during the period. American Century Companies Inc. purchased a new position in shares of Nutex Health in the fourth quarter valued at $1,362,000. Truist Financial Corp raised its stake in shares of Nutex Health by 22.2% during the 4th quarter. Truist Financial Corp now owns 35,570 shares of the company's stock valued at $1,127,000 after purchasing an additional 6,454 shares during the period. Drive Wealth Management LLC bought a new position in Nutex Health in the 4th quarter worth about $1,122,000. Finally, Legato Capital Management LLC grew its holdings in Nutex Health by 26.8% during the 4th quarter. Legato Capital Management LLC now owns 31,669 shares of the company's stock valued at $1,004,000 after buying an additional 6,697 shares in the last quarter. Institutional investors own 5.32% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, Maxim Group boosted their price target on shares of Nutex Health from $75.00 to $100.00 and gave the company a "buy" rating in a research report on Tuesday, April 8th.

View Our Latest Analysis on Nutex Health

Nutex Health Price Performance

NASDAQ NUTX traded down $3.36 during trading hours on Friday, reaching $114.63. 106,633 shares of the stock traded hands, compared to its average volume of 59,947. The stock has a 50 day simple moving average of $83.95 and a two-hundred day simple moving average of $53.48. Nutex Health Inc. has a 1 year low of $4.16 and a 1 year high of $152.51. The company has a debt-to-equity ratio of 3.36, a current ratio of 1.77 and a quick ratio of 1.74. The company has a market cap of $633.67 million, a price-to-earnings ratio of -12.21 and a beta of 0.27.

Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its earnings results on Monday, March 31st. The company reported $11.12 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.09) by $11.21. The business had revenue of $81.30 million during the quarter, compared to analyst estimates of $81.13 million. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%.

Insider Buying and Selling

In related news, CFO Jon Christian Bates acquired 1,000 shares of the stock in a transaction on Tuesday, April 8th. The stock was purchased at an average price of $81.81 per share, for a total transaction of $81,810.00. Following the completion of the transaction, the chief financial officer now owns 4,888 shares of the company's stock, valued at $399,887.28. This trade represents a 25.72 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. 38.52% of the stock is owned by corporate insiders.

Nutex Health Profile

(Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

Read More

Institutional Ownership by Quarter for Nutex Health (NASDAQ:NUTX)

Should You Invest $1,000 in Nutex Health Right Now?

Before you consider Nutex Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.

While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines